Drug intelligence / Profile preview

Boya

Development stage
Unknown
Lead developer
Jiangxi Boya Bio-Pharmaceutical
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous, Oral
01

Overview

Boya is a multi-use name in the pharmaceutical and medical fields, primarily referring to a specific intravenous immunoglobulin (IVIG) product and a traditional herbal remedy. **Boya IVIG**, developed by Boya Bio-Pharmaceutical Group, is a plasma-derived biologic containing human IgG antibodies. It is currently in Phase 3 clinical development (e.g., NCT06150833) as a replacement therapy for patients with primary immunodeficiency diseases (PID), including common variable immunodeficiency (CVID) and X-linked agammaglobulinemia (XLA), to maintain therapeutic IgG levels and prevent serious bacterial infections. Separately, **Badranj Boya** is the traditional name for the aromatic herb *Nepeta ruderalis* (Lamiaceae), which is used in traditional medicine for gastrointestinal and airway disorders. Research indicates that *Nepeta ruderalis* extracts possess spasmolytic and broncho-relaxant activities, likely mediated through the blockade of voltage-gated calcium channels. Additionally, the name Boya is associated with a brand of pulmonary calibration syringes, a multiplexing cold neutron spectrometer (BOYA), and geographic locations in Nepal.

Brand names
Boya IVIG
Other names
Badranj Boyaintravenous immunoglobulin (human)Nepeta ruderalis extract
02

Targets

FcγR (Low affinity immunoglobulin gamma Fc region receptor II-c)CaV (Voltage-gated calcium channel protein complex)

Beyond the preview

Go deeper on Boya.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Boya.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call